Use of a fermented milk containing L. casei for the manufacture of a composition for the prevention or treatment of a delayed-type hypersensitivity reaction
US8309074B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 20, 2006 |
| Grant date | Nov 13, 2012 |
| Priority date | — |
| Expiry date | Oct 1, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the field of probiotics. More particularly, the invention pertains to the use of a particular strain, Lactobacillus casei CNCM I-1518, which is present in Actimel®, for alleviating the symptoms of a delayed-type hypersensitivity reaction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.